All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Insulin-like Growth Factors in a clinical setting: Review of IGF-I

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F15%3A33154838" target="_blank" >RIV/61989592:15110/15:33154838 - isvavai.cz</a>

  • Alternative codes found

    RIV/00098892:_____/15:#0000891

  • Result on the web

    <a href="http://dx.doi.org/10.5507/bp.2015.041" target="_blank" >http://dx.doi.org/10.5507/bp.2015.041</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.5507/bp.2015.041" target="_blank" >10.5507/bp.2015.041</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Insulin-like Growth Factors in a clinical setting: Review of IGF-I

  • Original language description

    Interest in growth hormone (GH) is inextricably linked to the need for in depth understanding of the somatomedins (insulin-like growth factors) which are polypeptides structurally similar to insulin and with broad physiological aktivity. To date, the most commonly konwn is Insulin-Like Growth Factor I (IGF-I). Despite considerable current knowledge of IGF-I, however, its bioaktivity is incompletely understood. Measurement of IGF-I is of the utmost importance in the diagnosis and treatment of, for example acromegaly and growth hormone deficiency. The development of recombinant IGF-I, has allowed its use in such cases. Clinical practice, however, shows that few young/adult patients will benefit from treatment with the rIGF-I, mecasermin, given the numberof adverse effects found. This review focuses on current knowledge mainly related to IGF-I and the use of its recombinant form (fIGF-I) in clinical practice. Several functions of IGI-II have been elucidated but their clinical signifikanc

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FB - Endocrinology, diabetology, metabolism, nutrition

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    S - Specificky vyzkum na vysokych skolach

Others

  • Publication year

    2015

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Biomedical Papers-Olomouc

  • ISSN

    1213-8118

  • e-ISSN

  • Volume of the periodical

    159

  • Issue of the periodical within the volume

    3

  • Country of publishing house

    CZ - CZECH REPUBLIC

  • Number of pages

    5

  • Pages from-to

    347-351

  • UT code for WoS article

  • EID of the result in the Scopus database